ADVERSE REACTIONS AND INTERACTIONS LIMITING USE OF ANTIHYPERTENSIVE DRUGS

被引:61
作者
NIES, AS
机构
[1] VANDERBILT UNIV,SCH MED,DEPT PHARMACOL,DIV CLIN PHARMACOL,NASHVILLE,TN 37232
[2] VANDERBILT UNIV,SCH MED,DEPT MED,NASHVILLE,TN 37232
关键词
D O I
10.1016/0002-9343(75)90122-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:495 / 503
页数:9
相关论文
共 29 条
[1]  
ABLAD B, 1963, ACTA PHARMACOL TOX, V20, P1
[2]  
CARSTAIRS KC, 1966, LANCET, V2, P133
[3]   BLOOD-PRESSURE AND CARDIAC PERFORMANCE [J].
COHN, JN .
AMERICAN JOURNAL OF MEDICINE, 1973, 55 (03) :351-361
[4]   DEPENDENCE OF ARTERIAL-PRESSURE ON INTRAVASCULAR VOLUME IN TREATED HYPERTENSIVE PATIENTS [J].
DUSTAN, HP ;
BRAVO, EL ;
TARAZI, RC .
NEW ENGLAND JOURNAL OF MEDICINE, 1972, 286 (16) :861-+
[5]  
Effects of treatment on morbidity in hypertension, 1970, JAMA-J AM MED ASSOC, V213, P1143
[6]   HEPATIC INJURY CAUSED BY L-ALPHA-METHYLDOPA [J].
ELKINGTON, SG ;
SCHREIBER, WM ;
CONN, HO .
CIRCULATION, 1969, 40 (04) :589-+
[7]   TIME REQUIRED FOR COMPLETE RECOVERY FROM CHRONIC PROPRANOLOL THERAPY [J].
FAULKNER, SL ;
HOPKINS, JT ;
BOERTH, RC ;
YOUNG, JL ;
JELLETT, LB ;
NIES, AS ;
BENDER, HW ;
SHAND, DG .
NEW ENGLAND JOURNAL OF MEDICINE, 1973, 289 (12) :607-609
[8]  
GAFFNEY T E, 1969, Progress in Cardiovascular Diseases, V12, P52, DOI 10.1016/0033-0620(69)90035-8
[9]   METHYLDOPA FEVER [J].
GLONTZ, GE ;
SASLAW, S .
ARCHIVES OF INTERNAL MEDICINE, 1968, 122 (05) :445-+
[10]  
GULATI OD, 1966, CLIN PHARMACOL THER, V7, P510